Literature DB >> 9461362

Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group.

O Schofer1, B Mischo, W Püschel, K Harzer, M T Vanier.   

Abstract

UNLABELLED: An infant with an unusual clinical presentation and course of Niemann-Pick disease type C (NPC) is described. The baby presented with severe pulmonary involvement and hepatosplenomegaly at the age of 3 months and died of respiratory failure at the age of 7 months. Cell hybridization studies revealed that the infant belonged to the rare genetic complementation group 2. To our knowledge, this is the third reported case with early-lethal pulmonary involvement in NPC. All three reported patients belong to the minor complementation group 2. An elder brother of the present case had also died at 6 weeks of age from NPC with severe pulmonary involvement. The two complementation groups cannot be distinguished from each other by clinical, cellular and biochemical criteria except for severe pulmonary involvement which may be characteristic of the second group.
CONCLUSION: NPC may present in early infancy with severe pulmonary involvement mimicking interstitial pneumonia. Such manifestation may be characteristic of the rare genetic complementation group 2.

Entities:  

Mesh:

Year:  1998        PMID: 9461362     DOI: 10.1007/s004310050764

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

2.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

3.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

4.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

5.  Isolated splenomegaly as the presenting feature of Niemann-Pick disease type C.

Authors:  J Imrie; J E Wraith
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

6.  Pulmonary involvement in Niemann-Pick C type 1.

Authors:  Orna Staretz-Chacham; M Aviram; I Morag; A Goldbart; E Hershkovitz
Journal:  Eur J Pediatr       Date:  2018-07-31       Impact factor: 3.183

7.  Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.

Authors:  Charina M Ramirez; Benny Liu; Anna M Taylor; Joyce J Repa; Dennis K Burns; Arthur G Weinberg; Stephen D Turley; John M Dietschy
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

8.  Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.

Authors:  G Millat; K Chikh; S Naureckiene; D E Sleat; A H Fensom; K Higaki; M Elleder; P Lobel; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

9.  Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.

Authors:  Akshay Muralidhar; Ivan A Borbon; Dyadin M Esharif; Wangjing Ke; Rinu Manacheril; Michael Daines; Robert P Erickson
Journal:  Mol Genet Metab       Date:  2011-03-05       Impact factor: 4.797

10.  Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis.

Authors:  Gail Deutsch; Akshay Muralidhar; Ellen Le; Ivan A Borbon; Robert P Erickson
Journal:  Gene       Date:  2015-12-18       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.